Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ABCL

AbCellera Biologics Inc

Dec 06 • 04:00PM ET

4.85

Dollar change +0.35
Percentage change 7.78	%

Healthcare • Biotechnology • Canada • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.45	Insider Own	31.78%	Shs Outstand	286.85M	Perf Week	1.46%
Market Cap	1.41B	Forward P/E	-	EPS next Y	-0.51	Insider Trans	0.00%	Shs Float	197.97M	Perf Month	8.38%
Income	-129.14M	PEG	-	EPS next Q	-0.11	Inst Own	38.97%	Short Float / Ratio	13.87% / 16.90	Perf Quarter	-12.77%
Sales	50.39M	P/S	27.93	EPS this Y	-190.67%	Inst Trans	11.58%	Short Interest	27.47M	Perf Half Y	-33.65%
Book/sh	4.12	P/B	1.18	EPS next Y	-12.22%	ROA	-8.43%	Target Price	19.11	Perf Year	-59.28%
Cash/sh	2.79	P/C	1.74	EPS next 5Y	10.00%	ROE	-10.62%	52W Range	3.87 - 11.99	Perf YTD	-52.12%
Dividend	-	P/FCF	-	EPS past 5Y	308.35%	ROI	-10.27%	52W High	-59.55%	Beta	0.28
Dividend %	-	Quick Ratio	8.33	Sales past 5Y	507.44%	Gross Margin	-	52W Low	25.32%	ATR	0.29
Employees	495	Current Ratio	8.34	Sales Q/Q	-93.49%	Oper. Margin	-411.53%	RSI (14)	58.46	Volatility	8.11% 6.10%
Optionable	Yes	Debt/Eq	0.07	EPS Q/Q	-217.20%	Profit Margin	-256.27%	Rel Volume	1.02	Prev Close	4.50
Shortable	Yes	LT Debt/Eq	0.06	Earnings	Nov 02 AMC	Payout	0.00%	Avg Volume	1.62M	Price	4.85
Recom	1.20	SMA20	9.15%	SMA50	10.46%	SMA200	-21.47%	Volume	1,654,344	Change	7.78%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-05-23	Initiated	KeyBanc Capital Markets	Overweight	$6
Nov-06-23	Downgrade	The Benchmark Company	Buy → Hold
Oct-13-23	Resumed	Piper Sandler	Overweight	$20
Feb-28-23	Initiated	Cowen	Outperform
Dec-15-22	Initiated	Goldman	Buy	$30
Nov-16-22	Initiated	Truist	Buy	$29
Dec-21-21	Initiated	The Benchmark Company	Buy	$27
Nov-19-21	Initiated	Piper Sandler	Overweight	$33
Jan-05-21	Initiated	SVB Leerink	Outperform	$45
Jan-05-21	Initiated	Stifel	Buy	$59
Jan-05-21	Initiated	Credit Suisse	Outperform	$52
Jan-05-21	Initiated	BMO Capital Markets	Outperform	$48
Jan-05-21	Initiated	Berenberg	Buy	$53

Show Previous Ratings

Nov-16-23 04:05PM	AbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023 (Business Wire)
Nov-03-23 12:05PM	AbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023 (Business Wire) +6.09%
10:51AM	AbCellera Biologics Inc. (NASDAQ:ABCL) Q3 2023 Earnings Call Transcript (Insider Monkey)
08:42AM	Q3 2023 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents)
05:55AM	Prelude Therapeutics Inc (PRLD) Reports Q3 Financial Results and Strategic Pipeline Progress (GuruFocus.com)
05:30AM	Loading…
05:30AM	AbCellera Biologics (ABCL) Q3 2023 Earnings Call Transcript (Motley Fool)
Nov-02-23 05:56PM	AbCellera Biologics Inc (ABCL) Reports Q3 2023 Earnings: Revenue Drops to $7 Million (GuruFocus.com) +7.52%
04:05PM	AbCellera Reports Q3 2023 Business Results (Business Wire)
Nov-01-23 04:05PM	Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology (GlobeNewswire)
Oct-31-23 04:05PM	AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023 (Business Wire)
Oct-26-23 10:02AM	Earnings Preview: AbCellera Biologics Inc. (ABCL) Q3 Earnings Expected to Decline (Zacks)
Oct-11-23 04:05PM	AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023 (Business Wire)
Sep-29-23 12:43PM	25 Biggest Stocks with Negative Beta (Insider Monkey)
Sep-27-23 09:00AM	AbCellera Announces Two T-Cell Engager Presentations at SITC 2023 (Business Wire)
Sep-20-23 05:02PM	AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron (Business Wire)
07:03PM	Loading…
Sep-14-23 07:03PM	Insider Buying: Veronique Lecault Acquires 20,000 Shares of AbCellera Biologics Inc (GuruFocus.com)
Sep-13-23 09:00AM	AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology (Business Wire)
Aug-31-23 10:12PM	11 Cheap Small-Cap Stocks to Buy Before the Next Breakout (Insider Monkey) -6.03%
07:37AM	10 Stocks That Could 10X Over the Next 10 Years (Insider Monkey)
Aug-19-23 10:44AM	Billionaire Stan Druckenmillers Small-Cap Stock Picks (Insider Monkey)
Aug-04-23 10:23AM	Q2 2023 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents) -13.34%
01:00AM	AbCellera Biologics (ABCL) Q2 2023 Earnings Call Transcript (Motley Fool)
Aug-03-23 05:35PM	AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Q2 2023 Business Results (Business Wire)
Jul-26-23 01:17PM	10 Best Canadian Stocks Under $10 (Insider Monkey)
Jul-25-23 09:55AM	Does AbCellera Biologics Inc. (ABCL) Have the Potential to Rally 242.09% as Wall Street Analysts Expect? (Zacks)
Jul-24-23 04:05PM	AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights Request for Rehearing (Business Wire)
Jul-08-23 08:43PM	Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom (InvestorPlace)
Jul-06-23 04:05PM	AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023 (Business Wire)
Jun-17-23 09:52AM	AbCellera Biologics Insiders Added US$4.2m Of Stock To Their Holdings \ (Simply Wall St.)
06:50AM	Loading…
May-30-23 06:50AM	Daily Vickers Top Buyers & Sellers for 05/30/2023 (Argus Research)
May-29-23 04:05PM	AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023 (Business Wire)
May-27-23 08:43AM	Strong week for AbCellera Biologics (NASDAQ:ABCL) shareholders doesn't alleviate pain of one-year loss (Simply Wall St.)
May-24-23 02:32PM	UPDATE 1-AbCellera to make C$701 million co-investment in Canada (Reuters)
01:56PM	AbCellera to make C$701 million co-investment in Canada (Reuters)
01:30PM	These Small-Cap Biotech Stocks Have the Wind at Their Back (TheStreet.com)
01:10PM	AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients (Business Wire)
May-14-23 02:57PM	7 Growth Stocks That Could Double Your Money in 2023 (InvestorPlace)
May-06-23 08:03AM	AbCellera Biologics First Quarter 2023 Earnings: EPS Misses Expectations (Simply Wall St.)
May-05-23 10:13AM	Q1 2023 Abcellera Biologics Inc Earnings Call (Thomson Reuters StreetEvents) -9.38%
12:30AM	AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript (Motley Fool)
May-04-23 05:15PM	AbCellera Biologics Inc. (ABCL) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-27-23 10:02AM	AbCellera Biologics Inc. (ABCL) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Apr-24-23 07:46PM	7 Stocks Under $10 That Analysts Love (InvestorPlace)
Apr-17-23 09:10AM	AbCellera Presents New Data on T-Cell Engager Platform at AACR 2023 (Business Wire)
Apr-13-23 05:50AM	1 Sector Received $6.1 Billion in AI Investments Last Year: 3 Top Stocks to Buy (Motley Fool)
Apr-11-23 07:31PM	7 Best Stocks Under $10 to Buy in April (InvestorPlace)
04:05PM	AbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023 (Business Wire)
Apr-06-23 04:05PM	AbCellera to Report First Quarter 2023 Financial Results on May 4, 2023 (Business Wire)
Apr-05-23 01:40PM	7 Thrilling Biotech Stocks for Aggressive Investors to Buy (InvestorPlace)
Mar-22-23 03:26PM	7 Stocks to Bet On if You Want to Be Richer Than Elon Musk (InvestorPlace)
09:00AM	AbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease (Business Wire)
Mar-14-23 04:30PM	AbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023 (Business Wire)
Mar-12-23 08:09AM	Institutional investors may adopt severe steps after AbCellera Biologics Inc.'s (NASDAQ:ABCL) latest 9.9% drop adds to a year losses (Simply Wall St.)
Feb-23-23 04:05PM	AbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023 (Business Wire)
Feb-21-23 10:30PM	AbCellera Biologics (ABCL) Q4 2022 Earnings Call Transcript (Motley Fool) -7.30%
05:45PM	AbCellera Biologics Inc. (ABCL) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:05PM	AbCellera Reports Full Year 2022 Business Results (Business Wire)
Feb-02-23 02:19PM	The 7 Most Undervalued Biotech Stocks to Buy in February 2023 (InvestorPlace)
Feb-01-23 04:05PM	AbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023 (Business Wire)
Jan-24-23 04:05PM	AbCellera to Report Full Year 2022 Financial Results on February 21, 2023 (Business Wire)
08:48AM	Is the Options Market Predicting a Spike in AbCellera (ABCL) Stock? (Zacks)
Jan-23-23 11:00AM	AbCellera Biologics Clears Key Benchmark, Hitting 80-Plus RS Rating (Investor's Business Daily)
Jan-19-23 07:00PM	AbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent (Business Wire)
11:59AM	Does AbCellera Biologics (NASDAQ:ABCL) Deserve A Spot On Your Watchlist? (Simply Wall St.)
Jan-12-23 04:55AM	Strength Seen in Pliant Therapeutics, Inc. (PLRX): Can Its 8.3% Jump Turn into More Strength? (Zacks) +6.25%
Jan-05-23 09:09AM	AbCellera Biologics Inc.'s (NASDAQ:ABCL) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? (Simply Wall St.)
Jan-04-23 04:05PM	AbCellera to Present at the 41st Annual J.P. Morgan Healthcare Conference on January 11, 2023 (Business Wire)
Dec-22-22 05:08AM	Trade Alert: The CEO, President & Chairperson Of AbCellera Biologics Inc. (NASDAQ:ABCL), Carl Hansen, Has Just Spent US$859k Buying A Few More Shares (Simply Wall St.)
Dec-21-22 06:46AM	Daily Vickers Top Buyers & Sellers for 12/21/2022 (Argus Research)
Dec-16-22 10:02AM	AbCellera (ABCL) to Develop New Antibody Therapies With AbbVie (Zacks)
Dec-15-22 07:00AM	AbCellera and AbbVie Partner to Advance New Antibody Therapies (Business Wire)
Dec-14-22 08:18AM	Is There An Opportunity With AbCellera Biologics Inc.'s (NASDAQ:ABCL) 43% Undervaluation? (Simply Wall St.)
Dec-12-22 08:54AM	Implied Volatility Surging for AbCellera Biologics (ABCL) Stock Options (Zacks)
Dec-01-22 07:00AM	AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases (Business Wire)
Nov-29-22 04:10PM	IBD Stock Of The Day AbCellera Is Pulling Back Why Investors Should Be Paying Attention (Investor's Business Daily)
Nov-10-22 08:05AM	AbCellera Presents New Data on Further Development and Characterization of T-Cell Engager Platform at SITC 2022 (Business Wire) +9.31%
Nov-08-22 11:00PM	AbCellera Biologics Inc. (ABCL) Q3 2022 Earnings Call Transcript (Motley Fool)
06:35PM	AbCellera Biologics Inc. (ABCL) Q3 Earnings Miss Estimates (Zacks)
04:05PM	AbCellera Reports Q3 2022 Business Results (Business Wire)
Nov-04-22 04:05PM	AbCellera to Present at Upcoming Investor Conferences in November (Business Wire)
Nov-03-22 01:45PM	Abcellera Biologics Clears Technical Benchmark, Hitting 90-Plus RS Rating (Investor's Business Daily)
Nov-02-22 09:00AM	AbCelleras First Program with Regeneron in Multi-Target Collaboration Advances in Preclinical Development (Business Wire)
Nov-01-22 10:01AM	AbCellera Biologics Inc. (ABCL) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Oct-25-22 02:45PM	12 Best Stocks Under $50 (Insider Monkey)
Oct-21-22 09:55AM	Wall Street Analysts Believe AbCellera Biologics Inc. (ABCL) Could Rally 138%: Here's is How to Trade (Zacks)
Oct-11-22 04:05PM	AbCellera to Report Third Quarter 2022 Financial Results on November 8, 2022 (Business Wire)
10:40AM	Abcellera Biologics Stock Earns Relative Strength Rating Upgrade (Investor's Business Daily)
Oct-10-22 08:48AM	Implied Volatility Surging for AbCellera Biologics (ABCL) Stock Options (Zacks)
Oct-05-22 09:25AM	11 Cheap Healthcare Stocks To Invest In (Insider Monkey)
08:00AM	AbCellera Announces Presentation of Data from CD3 T-Cell Engager Platform at SITC 2022 (Business Wire)
Oct-03-22 06:45AM	AbCellera Biologics Inc. (NASDAQ:ABCL) institutional owners may be pleased with recent gains after 43% loss over the past year (Simply Wall St.)
Sep-26-22 09:21AM	10 Best Biotech Stocks Under $10 (Insider Monkey)
Sep-21-22 08:00AM	AbCellera Launches Second Phase of Global Headquarters Expansion to Advance Capabilities for Bringing New Medicines from Target to the Clinic (Business Wire)
Aug-24-22 06:15AM	CEO, President & Chairperson Carl Hansen Just Bought A Handful Of Shares In AbCellera Biologics Inc. (NASDAQ:ABCL) (Simply Wall St.)
Aug-18-22 08:50AM	Implied Volatility Surging for AbCellera (ABCL) Stock Options (Zacks)
Aug-10-22 01:20PM	Why AbCellera Biologics Rallied as Much as 24% on Wednesday (Motley Fool) +20.07%
12:30AM	AbCellera Biologics Inc. (ABCL) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-09-22 06:05PM	AbCellera Biologics Inc. (ABCL) Reports Q2 Loss, Misses Revenue Estimates (Zacks) -5.53%
04:05PM	AbCellera Reports Q2 2022 Business Results (Business Wire)

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Veronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hansen Carl L. G.	Chief Executive Officer	May 26	Option Exercise	2.70	56,125	151,538	561,250	May 30 01:14 PM
Thermopylae Holdings Ltd.	10% Owner	May 26	Buy	6.52	153,000	997,728	56,012,493	May 26 02:50 PM
Booth Andrew	Chief Financial Officer	May 26	Buy	6.85	14,500	99,325	153,000	May 26 02:53 PM
Lecault Veronique	Chief Operating Officer	May 05	Option Exercise	0.19	250,000	47,500	2,020,122	May 09 03:02 PM
Hansen Carl L. G.	Chief Executive Officer	Feb 22	Option Exercise	2.70	56,125	151,538	505,125	Feb 23 04:33 PM
Booth Andrew	Chief Financial Officer	Dec 20	Option Exercise	0.19	50,000	9,500	188,500	Dec 22 02:31 PM
Thermopylae Holdings Ltd.	10% Owner	Dec 16	Buy	10.10	85,102	859,249	55,859,493	Dec 20 10:18 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ABCL

AbCellera Biologics Inc

Upgrade your FINVIZ experience